Page last updated: 2024-08-26

fructose 2,6-diphosphate and Overweight

fructose 2,6-diphosphate has been researched along with Overweight in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Agius, L; Al-Oanzi, ZH; Alshawi, A; Arden, C; Fountana, S; Moonira, T; Patman, G; Petrie, JL; Reeves, HL; Tudhope, SJ1
Gutiérrez-Grobe, Y; Méndez-Sánchez, N; Ponciano-Rodríguez, G1

Reviews

1 review(s) available for fructose 2,6-diphosphate and Overweight

ArticleYear
Viral hepatitis infection and insulin resistance: a review of the pathophysiological mechanisms.
    Salud publica de Mexico, 2011, Volume: 53 Suppl 1

    Topics: Adult; Aged; Comorbidity; Cytokines; Diabetes Mellitus, Type 2; Energy Metabolism; Fatty Acids; Fructosediphosphates; Genotype; Gluconeogenesis; Hepatitis, Viral, Human; Humans; Insulin Resistance; Liver Diseases; Mexico; Middle Aged; Overweight; Prevalence; Risk Factors; Viral Proteins

2011

Other Studies

1 other study(ies) available for fructose 2,6-diphosphate and Overweight

ArticleYear
Opposite effects of a glucokinase activator and metformin on glucose-regulated gene expression in hepatocytes.
    Diabetes, obesity & metabolism, 2017, Volume: 19, Issue:8

    Topics: Active Transport, Cell Nucleus; Animals; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Cells, Cultured; Diet, Western; Enzyme Activators; Fructose; Fructosediphosphates; Gene Expression Regulation, Enzymologic; Glucokinase; Glucose-6-Phosphatase; Glucose-6-Phosphate; Hepatocytes; Hypoglycemic Agents; Male; Metformin; Mice, Inbred C3H; Overweight; Promoter Regions, Genetic; Pyruvate Kinase; Rats, Wistar; Thiazoles

2017